Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres

被引:22
作者
Yang, Fan [2 ]
Song, Feng-Lan [2 ]
Pan, Yu-Fang [2 ]
Wang, Zhao-Yang [3 ]
Yang, Yi-qun [2 ]
Zhao, Yao-Ming [1 ]
Liang, Shi-Zhong [3 ]
Zhang, Yong-Ming [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangdong Pharmaceut Univ, Dept Pharm, Guangzhou, Guangdong, Peoples R China
[3] S China Univ Technol, Inst Mat, Guangzhou, Guangdong, Peoples R China
关键词
Interferon-alpha; microspheres; poly(lactide-co-glycolide); viscosity; concentration; preparation; BIODEGRADABLE PLGA MICROSPHERES; COPOLY(LACTIC GLYCOLIC) ACID; SUSTAINED-RELEASE; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; INVIVO DEGRADATION; LEUPROLIDE ACETATE; PROTEIN RELEASE; POLYLACTIC ACID; PARTICLE-SIZE; GROWTH-FACTOR;
D O I
10.3109/02652040903052010
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
By a double emulsion solvent evaporation method, interferon-alpha (IFN-alpha) microspheres were prepared with poly(lactide-co-glycolide) (PLGA) and their characteristics, such as morphology, drug loading, encapsulation efficiency, in vitro release and degradation were evaluated. The IFN-alpha microspheres were prepared by different viscosities from 0.17-1.13 dL g(-1) and concentrations between 5-25% of PLGA, which not only affected the drug loading and encapsulation efficiency of IFN-alpha microspheres, but also strongly influenced the in vitro release. With smooth and porous surface, the drug loading and encapsulation efficiency of the microspheres prepared by 15% 0.89 dL g(-1) PLGA were 7.736% and 77.38%, respectively. The DSC curve of microspheres indicated IFN-alpha was loaded inside the microspheres. The degradation of microspheres was homogeneous and the mass loss was over 80% in 6 weeks. The release profile of microspheres showed a sustained fashion and the IFN-alpha released from microspheres maintained its bioactivity for 7 days.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 37 条
[1]   Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system [J].
Alpaslan, C ;
Irie, K ;
Takahashi, K ;
Ohashi, N ;
Sakai, H ;
Nakajima, T ;
Ozawa, H .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1996, 34 (05) :414-418
[2]   In vitro study of GDNF release from biodegradable PLGA microspheres [J].
Aubert-Pouëssel, A ;
Venier-Julienne, MC ;
Clavreul, A ;
Sergent, M ;
Jollivet, C ;
Montero-Menei, CN ;
Garcion, E ;
Bibby, DC ;
Menei, P ;
Benoit, JP .
JOURNAL OF CONTROLLED RELEASE, 2004, 95 (03) :463-475
[3]  
Beilharz, 2000, Pharm Sci Technol Today, V3, P193, DOI 10.1016/S1461-5347(00)00264-9
[4]   Nanosphere based oral insulin delivery [J].
Carino, GP ;
Jacob, JS ;
Mathiowitz, E .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :261-269
[5]   Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein [J].
Carrasquillo, KG ;
Stanley, AM ;
Aponte-Carro, JC ;
De Jésus, P ;
Costantino, HR ;
Bosques, CJ ;
Griebenow, K .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (03) :199-208
[6]   Characterization of PLGA microspheres for the controlled delivery of IL-1 alpha for tumor immunotherapy [J].
Chen, L ;
Apte, RN ;
Cohen, S .
JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) :261-272
[7]   Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres [J].
Diwan, M ;
Park, TG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :111-122
[8]   Interference of thiomersal in biologicals during protein estimation [J].
Dogar, V ;
Sokhey, J ;
Kumar, S ;
Sood, DK ;
Tahlan, AK .
BIOLOGICALS, 2002, 30 (04) :271-275
[9]   Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres [J].
Feng, L ;
Qi, XR ;
Zhou, XJ ;
Maitani, Y ;
Wang, SC ;
Jiang, Y ;
Nagai, T .
JOURNAL OF CONTROLLED RELEASE, 2006, 112 (01) :35-42
[10]  
Filipovic-Grcic J, 1999, Boll Chim Farm, V138, P14